FI101296B1 - Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi - Google Patents

Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi

Info

Publication number
FI101296B1
FI101296B1 FI915825A FI915825A FI101296B1 FI 101296 B1 FI101296 B1 FI 101296B1 FI 915825 A FI915825 A FI 915825A FI 915825 A FI915825 A FI 915825A FI 101296 B1 FI101296 B1 FI 101296B1
Authority
FI
Finland
Prior art keywords
cyclopentyloxycarbonyl
methylbenzenesulfonamide
methoxybenzoyl
indol
ylmethyl
Prior art date
Application number
FI915825A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI101296B (fi
FI915825A (fi
FI915825A0 (fi
Inventor
Martin Paul Edwards
John David Sherwood
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of FI915825A0 publication Critical patent/FI915825A0/fi
Publication of FI915825A publication Critical patent/FI915825A/fi
Application granted granted Critical
Publication of FI101296B1 publication Critical patent/FI101296B1/fi
Publication of FI101296B publication Critical patent/FI101296B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI915825A 1990-12-12 1991-12-11 Menetelmä yhdisteen N-£4-£5-(syklopentyylioksikarbonyyli)amino-1-metyy li-indol-3-yylimetyyli|-3-metoksibentsoyyli|-2-metyylibentseenisulfona midi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi FI101296B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027018A GB9027018D0 (en) 1990-12-12 1990-12-12 Heterocyclic compounds
GB9027018 1990-12-12

Publications (4)

Publication Number Publication Date
FI915825A0 FI915825A0 (fi) 1991-12-11
FI915825A FI915825A (fi) 1992-06-13
FI101296B1 true FI101296B1 (fi) 1998-05-29
FI101296B FI101296B (fi) 1998-05-29

Family

ID=10686919

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915825A FI101296B (fi) 1990-12-12 1991-12-11 Menetelmä yhdisteen N-£4-£5-(syklopentyylioksikarbonyyli)amino-1-metyy li-indol-3-yylimetyyli|-3-metoksibentsoyyli|-2-metyylibentseenisulfona midi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi

Country Status (28)

Country Link
US (1) US5294636A (ja)
EP (1) EP0490649B1 (ja)
JP (1) JP2650807B2 (ja)
KR (1) KR100194479B1 (ja)
CN (2) CN1032469C (ja)
AP (1) AP286A (ja)
AT (1) ATE145199T1 (ja)
AU (1) AU656344B2 (ja)
CA (1) CA2056067C (ja)
CZ (1) CZ288151B6 (ja)
DE (1) DE69123123T2 (ja)
DK (1) DK0490649T3 (ja)
ES (1) ES2094797T3 (ja)
FI (1) FI101296B (ja)
GB (2) GB9027018D0 (ja)
GR (1) GR3021605T3 (ja)
HK (1) HK81497A (ja)
HU (2) HU213109B (ja)
IE (1) IE914316A1 (ja)
IL (1) IL100090A (ja)
MX (1) MX9102475A (ja)
MY (1) MY108629A (ja)
NZ (1) NZ240940A (ja)
PH (1) PH30041A (ja)
RU (1) RU2107682C1 (ja)
SK (1) SK279018B6 (ja)
TW (1) TW222264B (ja)
ZA (1) ZA919772B (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE113581T1 (de) * 1990-05-04 1994-11-15 Ciba Geigy Ag Substituierte indole.
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
GR1001368B (el) * 1992-10-08 1993-10-29 Ici Plc Φαρμακευτικοί φορείς.
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
WO1995009615A1 (en) * 1993-10-01 1995-04-13 Astra Aktiebolag Process i
GB9723985D0 (en) * 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
IL139243A0 (en) * 2000-10-24 2001-11-25 Internat Specialty Products Is Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
JP2008531721A (ja) * 2005-03-03 2008-08-14 エラン・ファルマ・インターナショナル・リミテッド 複素環式アミド誘導体のナノ粒子状組成物
US20070197467A1 (en) * 2006-02-06 2007-08-23 Srinivasulu Rangineni Zafirlukast compositions
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
JP2010535234A (ja) * 2007-07-30 2010-11-18 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換インドール
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
CN103396353B (zh) * 2013-08-23 2015-05-20 海南通用三洋药业有限公司 一种扎鲁司特无定型态及其制备方法
EP3096760A1 (en) 2014-01-22 2016-11-30 Takeda GmbH Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier)
PT109030B (pt) 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
WO2018140858A1 (en) 2017-01-30 2018-08-02 Western New England University Thiol isomerases inhibitors and use thereof
AU2022276190A1 (en) 2021-05-19 2024-01-18 Quercis Pharma AG Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives

Also Published As

Publication number Publication date
GB2250743A (en) 1992-06-17
CS375891A3 (en) 1992-06-17
IL100090A0 (en) 1992-08-18
GR3021605T3 (en) 1997-02-28
AP9100341A0 (en) 1992-01-31
CN1032469C (zh) 1996-08-07
HU213109B (en) 1997-02-28
JPH04266872A (ja) 1992-09-22
GB2250743B (en) 1995-02-15
CN1074411C (zh) 2001-11-07
FI101296B (fi) 1998-05-29
MY108629A (en) 1996-10-31
ATE145199T1 (de) 1996-11-15
AU8899591A (en) 1992-06-18
AU656344B2 (en) 1995-02-02
CA2056067C (en) 2001-09-04
AP286A (en) 1993-09-26
FI915825A (fi) 1992-06-13
RU2107682C1 (ru) 1998-03-27
EP0490649A1 (en) 1992-06-17
HK81497A (en) 1997-06-27
DK0490649T3 (da) 1997-04-21
ES2094797T3 (es) 1997-02-01
CN1063100A (zh) 1992-07-29
ZA919772B (en) 1992-09-30
CN1148491A (zh) 1997-04-30
IL100090A (en) 1996-09-12
GB9126353D0 (en) 1992-02-12
CA2056067A1 (en) 1992-06-13
HU211125A9 (en) 1995-10-30
PH30041A (en) 1996-11-08
KR100194479B1 (ko) 1999-06-15
FI915825A0 (fi) 1991-12-11
HUT60717A (en) 1992-10-28
TW222264B (ja) 1994-04-11
NZ240940A (en) 1994-05-26
IE914316A1 (en) 1992-06-17
SK279018B6 (sk) 1998-05-06
EP0490649B1 (en) 1996-11-13
DE69123123D1 (de) 1996-12-19
JP2650807B2 (ja) 1997-09-10
HU913863D0 (en) 1992-02-28
MX9102475A (es) 1992-06-01
DE69123123T2 (de) 1997-03-06
US5294636A (en) 1994-03-15
KR920012031A (ko) 1992-07-25
CZ288151B6 (en) 2001-05-16
GB9027018D0 (en) 1991-01-30

Similar Documents

Publication Publication Date Title
FI101296B1 (fi) Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi
FI101193B1 (fi) Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalista muotoa sisältävän farmaseuttisen koostumuksen valmistamiseksi
IL126674A (en) Use of cyclic and heterocyclic compounds for preparing pharmaceutical compositions inhibiting impdh activity, pharmaceutical compositions containing the same and novel thiazole and oxazole urea derivatives
ZA925573B (en) 5-membered heterocyclic compounds processes for preparing them and pharmaceutical compositions containing these compounds
NO933093D0 (no) Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2h-indol-2-on hydroklorid
MY131288A (en) Pyrazole carboxanilide fungicides
FI950383A0 (fi) Uusi menetelmä kiraalisen (((2-bromietyyli)amino)metyyli)-2-nitro-1H-imidatsoli-1-etanolin ja sen sukuisten yhdisteiden valmistamiseksi
NZ229410A (en) Stable injectable pharmaceutical composition containing methyl 3-(4-(2-hydroxy-3-isopropylamino)propoxy) phenyl propionate hydrochloride (esmolol)
ZA913445B (en) Process for preparation of 1,5-(alkylimino)-1,5-dideoxy-d-glucitol and derivatives thereof
NO894845D0 (no) Fremgangsmaate og materialer for mikrobiell bioomdannelse av toluen og andre fenylforbindelser.
FI913554A0 (fi) Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
EP0006564A3 (en) 2-(3.5-disubstituted-2-hydroxyphenyl)-2h-benzotriazoles, stabilized compositions containing them and method for preparing azo compounds as starting materials for the benzotriazoles
DK0615971T3 (da) 5-(Piperazinylalkyl)-1,5-benzothiazepinoner, der kan anvendes som calciumantagonister
IL56513A (en) 3-(n-(acyloxyacetyl)-n-(substituted phenyl))-aminotetrahydro-2-furanone derivatives,their production and microbicidal compositions containing them
DK527585D0 (da) Monoethanolaminsaltet af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid paa saerlig krystallinsk form
NZ191067A (en) 2-(n-allyl-n-(substituted phenyl) amino)-2-imidazoline derivatives pharmaceutical compositions
NO179575C (no) Farmasöytisk preparat inneholdende en fysikalsk form av forbindelsen N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetyl-3-metoksybenzoylÅ-2-metylbenzensulfonamid
HU911239D0 (en) Process for producing 4-[3-(4-oxo-thiazolidinyl)]-1-butinyl-amine derivatives and pharmaceutical preparatives containing said compounds as active substance
PH19228A (en) N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof
EP0476391A3 (en) Anti-aids virus composition containing cepharanthine as active compound
NO960116D0 (no) Fremgangsmåte for fremstilling av en fysikalsk form av N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetylÅ-3-metoksybenzoylÅ-2-metylbenzensulfonamid
IT1188307B (it) Ribaltatore per impianti di imballaggio di materiali pallettizzabili
DE69221897D1 (de) Herstellung von 2-(pyridyl)ethyl substituierte phosphor-verbindungen
NO179248C (no) Fysikalsk form av N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetylÅ-3-metoksybenzoylÅ-2-metylbenzensulfonamid og fremgangsmåte for fremstilling derav
FI980376A0 (fi) N-/4-/5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli/-3-metoksibentsoyyli/-2-metyylibentseenisulfonamidin fysikaalista muotoa sisältävä farmaseuttinen koostumus

Legal Events

Date Code Title Description
FG Patent granted

Owner name: ZENECA LIMITED

GB Transfer or assigment of application

Owner name: ZENECA LIMITED

MA Patent expired